Beyond IC50 - A computational dynamic model of drug resistance in enzyme inhibition treatment.
J. Roadnight Sheehan, A. S. de Wijn, T. S. Freire, R. Friedman
The paper develops a computational model to study drug resistance in Abl1 inhibitors for CML, finding that inhibitory reduction prowess better predicts resistance than traditional metrics.
bioRxiv · Mar 21, 2024 · PreprintBiophysics